Pharmaceuticals
In a move that has sent shockwaves through the global healthcare industry, the U.S. Administration officially finalized a sweeping new trade policy on April 6, 2026, imposing 100% tariffs on branded (patented) pharmaceutical imports. The announcement, timed to coincide with the first anniversary of "Liberation Day"—the
Pharma
WASHINGTON, D.C. — In a move that has sent shockwaves through the global healthcare industry, President Trump signed a sweeping executive order yesterday, April 2, 2026, imposing a baseline 100% tariff on all imported patented pharmaceutical products. The aggressive trade measure is designed to force multinational drugmakers to shift production
TradePolicy
In a dramatic recalibration of American trade policy, the Trump administration has officially pivoted to Section 122 of the Trade Act of 1974 to sustain its sweeping tariff regime. This move follows a landmark February 20, 2026, Supreme Court ruling that stripped the executive branch of the power to use
SCOTUS
In a seismic shift for global trade policy, the U.S. Supreme Court issued a landmark 6-3 ruling on February 20, 2026, in the case of Learning Resources, Inc. v. Trump, effectively invalidating the administration's broad use of emergency powers to levy tariffs. The Court determined that the
Soybeans
The global soybean market is currently locked in a high-stakes "tug-of-war" as massive South American supply collides with a radical shift in American trade policy. On February 26, 2026, U.S. soybean futures reached a recent peak of $11.41 per bushel, buoyed by optimism surrounding a potential
Nvidia
In a landmark shift for global semiconductor trade, the U.S. government has officially transitioned from a policy of outright denial to a "managed access" framework for high-end artificial intelligence hardware. Nvidia (NASDAQ: NVDA) has received conditional approval to export its H200 AI chips to the Chinese market,
Agriculture
As the final days of 2025 wind down, the global agricultural sector is entering a period defined by a "cost-price squeeze" that has fundamentally altered the landscape for producers and investors alike. Heading into the 2026 season, the industry is grappling with a new era of volatility, where